Dean Richard Artis - 15 Jan 2023 Form 4 Insider Report for Annexon, Inc. (ANNX)

Role
EVP & Chief Scientific Officer
Signature
/s/ Jennifer Lew, as Attorney-in-Fact for Dean Richard Artis
Issuer symbol
ANNX
Transactions as of
15 Jan 2023
Net transactions value
$0
Form type
4
Filing time
18 Jan 2023, 18:43:23 UTC
Previous filing
12 Jan 2023
Next filing
21 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANNX Stock Option (Right to Buy) Award $0 +210,000 $0.000000 210,000 15 Jan 2023 Common Stock 210,000 $6.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from January 6, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.